Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 233 for “"VSV"”.

  1. Thermostability of lyophilized VSV-based vaccines

    … chain. Success of vesicular stomatitis virus (VSV) based vaccines has been highlighted by its increased adoption by pharmaceutical companies and most importantly, the recently approved vaccine for high consequence Ebola virus (EBOV). Lujo virus (LUJV) and Lassa virus (LASV), both arenaviruses, …

    manitoba Repository record for Thermostability of lyophilized VSV-based vaccines (opens in a new tab)

  2. CHARACTERIZATION OF ΔM51-VSV EXPRESSING BECLIN1

    … enhanced autophagy in the context of oncolytic VSV infection, a VSV mutant (ΔM51) expressing Beclin1 was constructed and characterized. It was determined through western blot analysis of autophagy marker LC3, that while VSV infection enhanced autophagy in infected cells, Beclin1 expression …

    mcmaster Repository record for CHARACTERIZATION OF ΔM51-VSV EXPRESSING BECLIN1 (opens in a new tab)

  3. VSV infection of resting and activated T lymphocytes

    Resting T lymphocytes are uniquely resistant to VSV even at high multiplicities of infection but they can be rendered fully permissive for VSV replication following in-vitro activation with monoclonal anti-CD3 and PMA with ionomycin. The block to VSV replication is at the level of viral RNA …

    ottawa-retro Repository record for VSV infection of resting and activated T lymphocytes (opens in a new tab)

  4. Identifying novel antiviral defences against VSV and HIV-1

    … ISGs in limiting Vesicular Stomatitis Virus (VSV) and Human Immunodeficiency Virus 1 (HIV-1) infection is incompletely understood. In this study, the role of ISGs and fever responses in restricting VSV and HIV-1 replication were investigated. The IFN system and fever are two interconnected …

    glasgow Repository record for Identifying novel antiviral defences against VSV and HIV-1 (opens in a new tab)

  5. A genetic strategy to improve VSV vectored vaccines against emerging bandaviruses

    … of a recombinant vesicular stomatitis virus (rVSV) vaccine encoding the SFTSV glycoproteins (rVSV-SFTSV) in an interferon-incompetent mouse model of lethal SFTSV infection. A single dose rVSV-SFTSV was well-tolerated and cross-protected mice from lethal SFTSV and mouse-adapted HRTV challenge. …

    penn Repository record for A genetic strategy to improve VSV vectored vaccines against emerging bandaviruses (opens in a new tab)

  6. DEVELOPMENT AND COMPARISON OF VSV AND MRNA VACCINES FOR MACHUPO VIRUS

    … recombinant Vesicular stomatitis virus (rVSV)-MACV vaccines expressing the MACV GPC in various genome positions: rVSVs expressing MACV GPC in the first position of the genome (rVSV-MACV1) and in the traditional glycoprotein gene position (rVSV-MACV5). rVSV-MACV1 expresses higher levels of …

    penn Repository record for DEVELOPMENT AND COMPARISON OF VSV AND MRNA VACCINES FOR MACHUPO VIRUS (opens in a new tab)

  7. MUTATIONS THAT POSITIVELY AFFECT BANDAVIRUS GLYCOPROTEIN FUNCTION ON VSV-VECTORED VACCINES

    … A recombinant vesicular stomatitis virus (rVSV) vaccine, which replaces the original VSV glycoprotein with the SFTSV glycoproteins, shows early promise for SFTSV as it induces strong immune responses that are protective against lethal challenge. However, rVSV-SFTSV is highly attenuated in …

    penn Repository record for MUTATIONS THAT POSITIVELY AFFECT BANDAVIRUS GLYCOPROTEIN FUNCTION ON VSV-VECTORED VACCINES (opens in a new tab)

  8. DEVELOPMENT OF REPLICATION-COMPETENT VSV-BASED VACCINES FOR PROTECTION AGAINST HANTAVIRUSES

    … immunogens in the vesicular stomatitis virus (VSV) genome on vector attenuation and vaccine efficacy. To generate the recombinant vaccine vectors, a VSV Indiana strain was modified by removing the native VSV glycoprotein and replacing it with one or two foreign glycoproteins; one derived from …

    montana-tech Repository record for DEVELOPMENT OF REPLICATION-COMPETENT VSV-BASED VACCINES FOR PROTECTION AGAINST HANTAVIRUSES (opens in a new tab)

  9. DEVELOPMENT OF REPLICATION-COMPETENT VSV-BASED VACCINES FOR PROTECTION AGAINST HANTAVIRUSES

    … immunogens in the vesicular stomatitis virus (VSV) genome on vector attenuation and vaccine efficacy. To generate the recombinant vaccine vectors, a VSV Indiana strain was modified by removing the native VSV glycoprotein and replacing it with one or two foreign glycoproteins; one derived from …

    montana Repository record for DEVELOPMENT OF REPLICATION-COMPETENT VSV-BASED VACCINES FOR PROTECTION AGAINST HANTAVIRUSES (opens in a new tab)

  10. Transcriptome-Wide Analysis of VSV Strains with Varying Ability to Block NF-κB

    Vesicular stomatitis virus (VSV) is a negative sense, single-stranded RNA (ssRNA) virus that is currently studied for its uses as a vaccine viral vector and its potential in oncolytic therapy. The M protein of VSV is the active participant in the virus’s abrogation of the host innate immune …

    rit Repository record for Transcriptome-Wide Analysis of VSV Strains with Varying Ability to Block NF-κB (opens in a new tab)

  11. Antagonism Between Trastuzumab and Oncolytic VSV is Overcome by Conjugation to a Microtubule Destabilizer

    … leaving normal cells unharmed. One such OV, VSVΔ51, replicates in interferon (IFN) defective cells, a characteristic of approximately 70% of tumours. We hypothesized that the combination of HER2 targeting therapies with VSVΔ51 could improve therapeutic efficacy. We found that HER2 …

    ottawa-retro Repository record for Antagonism Between Trastuzumab and Oncolytic VSV is Overcome by Conjugation to a Microtubule Destabilizer (opens in a new tab)

  12. Developing a Novel Pharmacoviral Anti-Cancer Strategy Combining Targeted Immunotherapy and Oncolytic Rhabdovirus VSV∆51

    … with oncolytic vesicular stomatitis virus (VSVΔ51). We demonstrated that the clinically-approved anti-HER2 ADC, trastuzumab emtansine (T-DM1, Kadcyla®) synergizes with VSVΔ51 in HER2-positive tumours to improve overall survival and reduce tumour burden (Chapter 2). Kadcyla® consists of …

    ottawa-retro Repository record for Developing a Novel Pharmacoviral Anti-Cancer Strategy Combining Targeted Immunotherapy and Oncolytic Rhabdovirus VSV∆51 (opens in a new tab)

  13. Characterizing the CNS protection induced by systemic administration of the oncolytic mutant virus DeltaM51-VSV

    Direct brain infection with VSV in mice, including the attenuated DeltaM51 strain, results in widespread viral replication, leading to irreversible and often fatal damage. When DeltaM51-VSV is administered i.v., a trace amount of the virus is found within the brain, but is eventually cleared …

    ottawa-retro Repository record for Characterizing the CNS protection induced by systemic administration of the oncolytic mutant virus DeltaM51-VSV (opens in a new tab)

  14. Investigating the role of pericyte infection in Vesicular Stomatitis Virus stimulated immune activation

    … have observed that Vesicular Stomatitis Virus (VSV), an OV, infects pericytes in the TME of various murine tumor models. Pericytes are vascular mural cells that maintain blood vessel physiology and take part in the inflammatory response. Despite a lack of tumor cell infections in our model, VSV …

    calgary Repository record for Investigating the role of pericyte infection in Vesicular Stomatitis Virus stimulated immune activation (opens in a new tab)

  15. Characterization of the S2 isolate of vesicular stomatitis virus

    … of RNA virus replication. Attenuated mutants of VSV have led to important discoveries about viral function, particularly genome replication and mRNA transcription. S2 VSV is small plaque isolate of VSV initially described to be attenuated in vivo but still able to induce a robust interferon …

    bu Repository record for Characterization of the S2 isolate of vesicular stomatitis virus (opens in a new tab)

  16. A Study of the Pseudotypes of Vesicular Stomatitis Virus and Murine Leukemia Viruses

    … of murine leukemia virus infected cells with VSV produces a certain proportion of pseudotype particles which have the genome of VSV and envelope antigen characteristics of murine leukemia virus, i.e. these particles cannot be neutralized by anti-VSV antiserum. Pseudotypes of VSV and Friend …

    mcmaster Repository record for A Study of the Pseudotypes of Vesicular Stomatitis Virus and Murine Leukemia Viruses (opens in a new tab)

  17. Maintenance and transmission of vesicular stomatitis viruses: New data for an old puzzle

    … and rodent samples were collected from suspected VSV-NJ enzootic areas over 2 consecutive field seasons (1996-1997) and from southern Arizona only during 1998. Insect samples were screened for arboviruses, and rodent sera were tested for the presence of VSV-NJ and VSV-IN neutralizing antibodies. …

    arizona-thes Repository record for Maintenance and transmission of vesicular stomatitis viruses: New data for an old puzzle (opens in a new tab)

  18. Roles of cellular proteins in replication of vesicular stomatitis virus

    Vesicular stomatitis virus (VSV) is an enveloped non-segmented negative-stranded RNA virus and is a model to study different aspects of molecular biology and immunopathogenesis of viruses. To indentify cellular proteins that interact with VSV P protein, a subunit of the viral RNA-dependent RNA …

    nebraska Repository record for Roles of cellular proteins in replication of vesicular stomatitis virus (opens in a new tab)

Page 1 of 12